Skip to content
Recall Observatory FDA recall evidence

Drug product

Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.

D-1178-2023

September 12, 2023

Class III

Product summary

Firm
Tolmar, Inc.
Event
Event 93044
Status
Terminated
Classification
Class III
Quantity
2990 cartons
Official record key
drug-enforcement:D-1178-2023

Official wording

Reason: Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

Code information: Lot: 13635A1, Exp. 07/31/2024

Distribution pattern: Nationwide in the US.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent